BioRestorative Therapies
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $19 | $11 | $303 | $25 |
Gross Profit | -34 | -51 | 294 | 22 |
EBITDA | -3,772 | -2,985 | -2,603 | -4,755 |
EBIT | -3,825 | -3,038 | -2,656 | -4,807 |
Net Income | -3,207 | -3,038 | -2,656 | -5,339 |
Net Change In Cash | 19 | 11 | 303 | 25 |
Free Cash Flow | -2,451 | -2,901 | -2,693 | -2,815 |
Cash | 1,511 | 602 | 1,555 | 1,228 |
Basic Shares | 8,876 | 9,116 | 8,740 | 8,357 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $359 | $401 | $145 | $119 |
Gross Profit | 335 | 372 | 145 | 119 |
EBITDA | -15,437 | -11,366 | -14,971 | -18,742 |
EBIT | -15,647 | -11,555 | -15,137 | -18,863 |
Net Income | -14,241 | -8,979 | -10,417 | -13,222 |
Net Change In Cash | 359 | 401 | 145 | 119 |
Free Cash Flow | -10,905 | -8,336 | -6,601 | -6,353 |
Cash | 1,511 | 547 | 884 | 1,713 |
Basic Shares | 8,993 | 7,763 | 4,218 | 3,617 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.32 |
2025-09-30 | -$0.33 |
2025-06-30 | -$0.30 |
